Literature DB >> 282079

Increased ratio between serum beta- and alpha-lipoproteins during diuretic therapy: an adverse effect?

Z Glück, G Baumgartner, P Weidmann, E Peheim, C Bachmann, R Mordasini, J Flammer, G Keusch.   

Abstract

1. The effect of diuretic therapy on serum lipids and lipoprotein fractions was evaluated in 16 normal or labile hypertensive subjects who received in cross-over fashion chlorthalidone, frusemide or mefruside, each for 4 weeks (group A); and in 13 patients with essential hypertension treated with chlorthalidone for 6 weeks (group B). 2. All three diuretics significantly increased the ratio between serum beta- and alpha-lipoprotein fractions. This was due to an increase of the serum beta-lipoprotein fraction while the alpha-lipoprotein fraction was not changed significantly (group A) or decreased (group B). Serum cholesterol or triglycerides tended to be increased, but mean changes were often not significant. 3. The observed alterations in serum lipoproteins are consistent with the possibility of an increased risk for coronary heart disease which could offset partly the beneficial effects of a lowered blood pressure in diuretic-treated patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282079     DOI: 10.1042/cs055325s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  15 in total

1.  Effects of diuretics alone or in combination with beta-adrenoceptor blockers on serum lipoproteins.

Authors:  P Weidmann; H Schiffl; K Boehringer; A Meier; R Mordasini; W Riesen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  The effects of diuretics and adrenergic-blocking agents on plasma lipids.

Authors:  J J Rohlfing; J D Brunzell
Journal:  West J Med       Date:  1986-08

Review 3.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

4.  Effects of diuretics on plasma lipoproteins in healthy men.

Authors:  C Joos; H Kewitz; D Reinhold-Kourniati
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

5.  Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.

Authors:  A Lehtonen; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 6.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

Review 7.  The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

Review 8.  [Antihypertensive therapy and lipid metabolism].

Authors:  W Krone; D Müller-Wieland; H Greten
Journal:  Klin Wochenschr       Date:  1984-03-01

9.  [Blood pressure during isometric and dynamic exercise under long-term antihypertensive treatment with beta receptor blockaders and diuretics].

Authors:  M Middeke; H Holzgreve
Journal:  Klin Wochenschr       Date:  1983-12-15

10.  Serum lipoproteins in patients with mild renal disease treated with the diuretic muzolimine.

Authors:  H Schiffl; P Weidmann; R Mordasini; K Boehringer; W Riesen; C Bachmann
Journal:  Klin Wochenschr       Date:  1982-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.